A Phase I Study of SIM0532 in Adult Participants With Advanced Solid Tumors

by | Aug 11, 2026 | Clinical Trials | 0 comments

​ Conditions: Histologically or Cytologically Confirmed Advanced Solid Tumors

Interventions: Drug: SIM0532 Tablets

Sponsors: Jiangsu Simcere Pharmaceutical Co., Ltd.; Shanghai Xianwei Medical Technology Co., Ltd.

Active, not recruiting Conditions: Histologically or Cytologically Confirmed Advanced Solid Tumors
Interventions: Drug: SIM0532 Tablets
Sponsors: Jiangsu Simcere Pharmaceutical Co., Ltd.; Shanghai Xianwei Medical Technology Co., Ltd.
Active, not recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *